Structured evidence table for Pea Protein Muscle Recovery Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Pea Protein Muscle Recovery Randomized Trial | Background This randomized, double-blind, placebo-controlled trial examined the effects of a chickpea protein hydrolysate (CPH) on biomarkers associated with exercise-induced muscle damage and inflammation in federated male road cyclists. | 4 | García-Durán J (2026) | Effects of a chickpea protein hydrolysate on exercise-induced biomarkers of muscle damage and inflammation in federated road cyclists. |
| Pea Protein Muscle Recovery Randomized Trial | LDH decreased in the EXP group while increasing slightly in the placebo group, whereas CRP decreased in EXP and increased in PLA. | 4 | García-Durán J (2026) | Effects of a chickpea protein hydrolysate on exercise-induced biomarkers of muscle damage and inflammation in federated road cyclists. |
| Pea Protein Muscle Recovery Randomized Trial | The high baseline protein intake (>2 g/kg/day) and short intervention duration may have limited changes in body composition, nevertheless, the observed biomarker responses suggest that CPH supplementation may influence selected physiological processes associated with exercise-induced inflammation and cellular stress. | 4 | García-Durán J (2026) | Effects of a chickpea protein hydrolysate on exercise-induced biomarkers of muscle damage and inflammation in federated road cyclists. |
| Pea Protein Muscle Recovery Randomized Trial | Methods Twenty-four participants completed a 14-day intervention receiving either 12 g/day of chickpea protein hydrolysate (EXP) or a placebo (PLA) following training sessions. | 4 | García-Durán J (2026) | Effects of a chickpea protein hydrolysate on exercise-induced biomarkers of muscle damage and inflammation in federated road cyclists. |
| Pea Protein Muscle Recovery Randomized Trial | We establish a structured framework to separately report evidence from preclinical animal models and clinical human trials, evaluating acute ( 7 days) horizons across three domains: (i) neurocognitive function/mood, (ii) gut microbiota/hormonal responses, and (iii) aminoacidemia/metabolic-inflammatory responses in aging cohorts. | 4 | Hao S (2026) | Comparative effects of pea protein vs. dairy proteins (α-lactalbumin and casein) on aminoacidemia, exercise performance, gut microbiota, hormonal responses, neurocognitive function, mood, and metabolic-inflammatory responses in older adults. |
| Pea Protein Muscle Recovery Randomized Trial | This narrative review comprehensively contrasts the physiological impacts of plant-based protein (focusing on pea protein isolates and matrices) vs. | 4 | Hao S (2026) | Comparative effects of pea protein vs. dairy proteins (α-lactalbumin and casein) on aminoacidemia, exercise performance, gut microbiota, hormonal responses, neurocognitive function, mood, and metabolic-inflammatory responses in older adults. |
| Pea Protein Muscle Recovery Randomized Trial | dairy-derived proteins (including intact casein and whey protein variants, emphasizing the rapid-digesting α-lactalbumin fraction). | 4 | Hao S (2026) | Comparative effects of pea protein vs. dairy proteins (α-lactalbumin and casein) on aminoacidemia, exercise performance, gut microbiota, hormonal responses, neurocognitive function, mood, and metabolic-inflammatory responses in older adults. |
Source documents